The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
IL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842
TH17 cells in development: an updated view of their molecular identity and genetic programming
Dong, C. (2008) · Nature reviews. Immunology · doi:10.1038/nri2295 · Cited by 1,064
Interleukin-17 promotes angiogenesis and tumor growth
Numasaki, M. (2003) · Blood · doi:10.1182/blood-2002-05-1461 · Cited by 834
Zhang, J.-P., Yan, J., Xu, J., Pang, X.-H., Chen, M.-S., Li, L., Wu, C., Li, S.-P., & Zheng, L. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.033 · Cited by 535
Numasaki, M., Watanabe, M., Suzuki, T., Takahashi, H., Nakamura, A., McAllister, F., Hishinuma, T., Goto, J., Lotze, M. T., Kolls, J. K., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6177 · Cited by 416
Protumor vs Antitumor Functions of IL-17
Murugaiyan, G., & Saha, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901017 · Cited by 369
Serum interleukin‐6 levels reflect the disease status of colorectal cancer
Chung, Y., & Chang, Y. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.10269 · Cited by 353
Generation and regulation of human CD4 + IL-17-producing T cells in ovarian cancer
Miyahara, Y., Odunsi, K., Chen, W., Peng, G., Matsuzaki, J., & Wang, R.-F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710686105 · Cited by 279
Kuang, D.-M., Peng, C., Zhao, Q., Wu, Y., Chen, M.-S., & Zheng, L. (2010) · Hepatology · doi:10.1002/hep.23291 · Cited by 263
Zhu, X., Mulcahy, L. A., Mohammed, R. A., Lee, A. H., Franks, H. A., Kilpatrick, L., Yilmazer, A., Paish, E. C., Ellis, I. O., Patel, P. M., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr2195 · Cited by 250
Calviello, G., Di Nicuolo, F., Gragnoli, S., Piccioni, E., Serini, S., Maggiano, N., Tringali, G., Navarra, P., Ranelletti, F. O., & Palozza, P. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh265 · Cited by 244
Steiner, G. E., Newman, M. E., Paikl, D., Stix, U., Memaran‐Dagda, N., Lee, C., & Marberger, M. J. (2003) · The Prostate · doi:10.1002/pros.10238 · Cited by 238
Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients
Chen, X., Wan, J., Liu, J., Xie, W., Diao, X., Xu, J., Zhu, B., & Chen, Z. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.11.013 · Cited by 217
Self-citationHigh prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas
Le Gouvello, S., Bastuji-Garin, S., Aloulou, N., Mansour, H., Chaumette, M.-T., Berrehar, F., Seikour, A., Charachon, A., Karoui, M., Leroy, K., et al. (2008) · Gut · doi:10.1136/gut.2007.123794 · Cited by 214
Nakasaki, T., Wada, H., Shigemori, C., Miki, C., Gabazza, E. C., Nobori, T., Nakamura, S., & Shiku, H. (2002) · American Journal of Hematology · doi:10.1002/ajh.10061 · Cited by 203
Danese, S., & Mantovani, A. (2010) · Oncogene · doi:10.1038/onc.2010.109 · Cited by 199
Meng, Y., Beckett, M. A., Liang, H., Mauceri, H. J., van Rooijen, N., Cohen, K. S., & Weichselbaum, R. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2995 · Cited by 181
Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells
Takahashi, H., Numasaki, M., Lotze, M. T., & Sasaki, H. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.11.012 · Cited by 153
Expression of IL-17 mRNA in Ovarian Cancer
Kato, T., Furumoto, H., Ogura, T., Onishi, Y., Irahara, M., Yamano, S., Kamada, M., & Aono, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4618 · Cited by 152
Numasaki, M., Lotze, M. T., & Sasaki, H. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.01.014 · Cited by 124
Antiangiogenesis drug promising for metastatic colorectal cancer
McCarthy, M. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13603-3 · Cited by 94
Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma.
Shibusa, T., Shijubo, N., & Abe, S. (1998) · PubMed · doi:10.11501/3154415 · Cited by 92
IL-6 and VEGF in small cell lung cancer patients.
Wójcik, E., Jakubowicz, J., Skotnicki, P., Sas-Korczyńska, B., & Kulpa, J. (2010) · PubMed · Cited by 45
Cited by
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
The role of microenvironment in tumor angiogenesis
Jiang, X., Wang, J., Deng, X., Xiong, F., Zhang, S., Gong, Z., Li, X., Cao, K., Deng, H., He, Y., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01709-5 · Cited by 761
Lee, W. S., Yang, H., Chon, H. J., & Kim, C. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00500-y · Cited by 688
Metadata
- Authors
- Liu, J., Duan, Y., Cheng, X., Chen, X., Xie, W., Long, H., Lin, Z., & Zhu, B.
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 407
- Issue
- 2
- Pages
- 348-354
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2085332471
- Cited by
- 361
- References
- 25
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.